Research and Markets has announced the addition of the "Amyotrophic Lateral Sclerosis Market - Forecast (2014-2021)" report to their offering.
Amyotrophic lateral sclerosis (ALS) is a neurological disease and also termed as Lou Gehrig's disease which results in a specific disorder that involves the death of neurons that control voluntary muscles. This is a fast progressing, invariably fatal neurological disease that attacks and damages the nerve cells (neurons) which responsible for controlling voluntary muscles. This disease is classified amongst group of disorders known as motor neuron diseases which involves gradual degeneration and death of motor neurons located in the brain, brain stem, and spinal cord.
Motor Neurons acts as controlling units and vital communication links between the nervous system and the voluntary muscles of the body. Initial symptoms of this disease include fasciculation, cramps, tight and stiff muscles, muscle weakness affecting an arm or a leg, slurred and nasal speech, or difficulty chewing or swallowing which are generally overlooked or ignored.
Globally North America contributed highest revenues in Amyotrophic lateral sclerosis market due high number of reported instances and deep reach of the treatments to the large number of population followed by Europe and Asia-Pacific regions as the second and third largest markets for Amyotrophic lateral sclerosis. Developing medical infrastructure in the emerging economies is expected to drive the growth of Amyotrophic lateral sclerosis market in these economies in the near future.
Key Topics Covered:
1. Market Overview
2. Executive Summary
3. Market Landscape
4. Market Forces
5. Strategic Analysis
6. Global Amyotrophic Lateral Sclerosis Market, By Drug Type (2014-2021)
7. Global Amyotrophic Lateral Sclerosis Market, By Treatment Type (2014-2021)
8. Global Amyotrophic Lateral Sclerosis Market, By Distribution Partners(2014-2021)
9. Global Amyotrophic Lateral Sclerosis Market, By Geography (2014-2021)
10. Amyotrophic Lateral Sclerosis - Market Entropy
11. Company Profiles (Top 10 Companies)
For more information about this report visit http://www.researchandmarkets.com/research/7wn6cl/amyotrophic
View source version on businesswire.com: http://www.businesswire.com/news/home/20161118005230/en/Business Wire
Last updated on: 18/11/2016
PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.